Safety outcomes of oral anticoagulants in patients with an indication of anti-coagulants after TAVR: A meta-analysis

Affiliations

• ¹ Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
• ² Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Institute of Medicine, National Research Mordovia State University, Saransk, Russia.
• ³ Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Faculty of Medicine, Menoufia University, Menoufia, Egypt.
• ⁴ The Brooklyn Hospital Center, Brooklyn, NY, USA.
• ⁵ Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Faculty of Medicine, Zagazig University, Zagazig, Egypt.
• ⁶ Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.
• ⁷ Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
• ⁸ Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
• ⁹ University of Texas MD Anderson, Houston, TX, USA.
• ¹⁰ John Ochsner Heart and Vascular Institute, Department of Cardiovascular Diseases, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA. Electronic address: jtafursoto@ochsner.org.